WOBURN, MA / ACCESSWIRE / December 3, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic...
Biofrontera completes a $4.2 million secured convertible note private placement to support operations and growth initiatives.Quiver AI SummaryBiofrontera Inc. has announced the completion of a $4.2 million...
Biofrontera reported Q3 2024 revenues of $9 million, affected by Hurricane Milton, with notable Ameluz sales growth and FDA approval.Quiver AI SummaryBiofrontera Inc. reported total revenues of $9.0 million...
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...